Detection of AmpC β-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory

Clinical Microbiology and Infection

Volumn 16, Issue 2, 2010, Pages 165-170

  Pitout, J D D ^a   Le, P G ^a   Moore, K L ^a   Church, D L ^a,b   Gregson, D B ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

AmpC lactamases; Disk test; Laboratory detection

Indexed keywords

BENZENEBORONIC ACID; BETA LACTAMASE AMPC; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; CLINICAL EFFECTIVENESS; DISK CONFIRMATION TEST; ESCHERICHIA COLI; FALSE POSITIVE RESULT; KLEBSIELLA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEUS MIRABILIS; RELIABILITY; SALMONELLA; SCREENING TEST; URINALYSIS;

ESCHERICHIA COLI; KLEBSIELLA; PROTEUS MIRABILIS; SALMONELLA;

EID: 74549214458     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02756.x     Document Type: Article

References (22)

1. Jacoby GA, Munoz-Price LS. The new β-lactamases. N Engl J Med 2005, 352:380-391.
2. Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 2002, 46:1-11.
3. Mulvey MR, Bryce E, Boyd DA. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother 2005, 49:358-365.
4. Forward KR, Willey BM, Low DE. Molecular mechanisms of cefoxitin resistance in Escherichia coli from the Toronto area hospitals. Diagn Microbiol Infect Dis 2001, 41:57-63.
5. Pitout JD, Gregson DB, Church DL, Laupland KB. Population-based laboratory surveillance for AmpC β-lactamase-producing Escherichia coli, Calgary. Emerg Infect Dis 2007, 13:443-448.
6. Doi Y, Paterson DL. Detection of plasmid-mediated class C β-lactamases. Int J Infect Dis 2007, 11:191-197.
7. Coudron PE. Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 2005, 43:4163-4167.
8. Yagi T, Wachino J, Kurokawa H. Practical methods using boronic acid compounds for identification of class C β-lactamase-producing Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 2005, 43:2551-2558.
9. Pitout JD, Reisbig MD, Mulvey M. Association between handling of pet treats and infection with Salmonella enterica serotype Newport expressing the AmpC β-lactamase, CMY-2. J Clin Microbiol 2003, 41:4578-4582.
10. Perez-Perez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
11. Performance Standards for Antimicrobial Susceptibility Testing; 18th Informational Supplement M100-S18 2008, Wayne, PA, CLSI
12. Nasim K, Elsayed S, Pitout JD, Conly J, Church DL, Gregson DB. New method for laboratory detection of AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae. J Clin Microbiol 2004, 42:4799-4802.
13. Pai H, Kang CI, Byeon JH. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-β-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2004, 48:3720-3728.
14. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the foss of an outer membrane protein. Antimicrob Agents Chemother 1997, 41:563-569.
15. Ruppe E, Bidet P, Verdet C, Arlet G, Bingen E. First detection of the Ambler class C 1 AmpC β-lactamase in Citrobacter freundii by a new, simple double-disk synergy test. J Clin Microbiol 2006, 44:4204-4207.
16. Woodford N, Reddy S, Fagan EJ. Wide geographic spread of diverse acquired AmpC β-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J Antimicrob Chemother 2007, 59:102-105.
17. Bauernfeind A, Schneider I, Jungwirth R, Sahly H, Ullmann U. A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob Agents Chemother 1999, 43:924-931.
18. Ohana S, Leflon V, Ronco E. Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC β-lactamase in a teaching hospital admitting disabled patients. Antimicrob Agents Chemother 2005, 49:2095-2097.
19. Black JA, Thomson KS, Buynak JD, Pitout JD. Evaluation of β-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC β-lactamases in well-characterized clinical strains of Klebsiella spp. J Clin Microbiol 2005, 43:4168-4171.
20. Black JA, Thomson KS, Pitout JD. Use of β-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC β-lactamases. J Clin Microbiol 2004, 42:2203-2206.
21. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007, 20:440-458.
22. Anderson KF, Lonsway DR, Rasheed JK. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007, 45:2723-2725.